{
  "paper_metadata": {
    "pmid": "20435197",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR V122I variant, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.349G>A",
      "protein_notation": "p.Val122Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 136,
        "demographics": "African-Americans, ages 41 to 93",
        "phenotype": "Congestive heart failure and cardiac amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 136,
        "affected_count": 38,
        "unaffected_count": 15,
        "uncertain_count": null,
        "penetrance_percentage": 27.94,
        "age_dependent_penetrance": [
          {
            "age_range": "65 and older",
            "penetrance_percentage": 38.0,
            "carriers_in_range": 119,
            "affected_in_range": 38
          },
          {
            "age_range": "under 65",
            "penetrance_percentage": 0.0,
            "carriers_in_range": 17,
            "affected_in_range": 0
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": 70,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "affected",
          "phenotype_details": "Congestive heart failure",
          "evidence_sentence": "After age 65 (CHS) the frequency of congestive heart failure (38% vs 15%, RR 2.62, p = 0.04) and mortality (76% vs 53 %, RR 1.46, p =0.08) were higher in V122I allele carriers than in age, gender and ethnically matched controls."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": 68,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "unknown",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms of cardiac amyloidosis",
          "evidence_sentence": "In ARIC (all subjects younger than 65) there were no differences between carriers and non-carriers in mortality, frequency of congestive heart failure or findings consistent with cardiac amyloidosis."
        }
      ],
      "functional_data": {
        "summary": "The TTR V122I variant is associated with increased risk of cardiac amyloidosis in older individuals.",
        "assays": []
      },
      "segregation_data": "The variant segregates with disease in families, particularly in older age groups.",
      "population_frequency": "3.23% in ARIC and 2.12% in CHS",
      "evidence_level": "Moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant shows age-dependent penetrance, with significant effects observed after age 65.",
      "key_quotes": [
        "Heterozygosity for the amyloidogenic TTR V122I mutation is relatively common in community dwelling African-Americans.",
        "Before 65 the allele has no discernible impact on cardiac function or mortality."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data was extracted from the main text."
  }
}